Huang, L., Wang, X., Zhou, L., Di, L., Zheng, H., Jiang, Z., . . . Shao, Z. (2019). Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer. Cancer Chemother Pharmacol.
Citação norma ChicagoHuang, Liang, et al. "Oral Vinorelbine Versus Intravenous Vinorelbine, in Combination With Epirubicin As First-line Chemotherapy in Chinese Patients With Metastatic Breast Cancer." Cancer Chemother Pharmacol 2019.
Citação norma MLAHuang, Liang, et al. "Oral Vinorelbine Versus Intravenous Vinorelbine, in Combination With Epirubicin As First-line Chemotherapy in Chinese Patients With Metastatic Breast Cancer." Cancer Chemother Pharmacol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.